JPRN-UMIN000013223
Completed
Phase 1
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer - Phase I study of CBDCA+nab-PTX+TRT with locally advanced NSCLC
Conditionsnon small cell lung cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- non small cell lung cancer
- Sponsor
- Kochi University
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with active lung disease such as interstitial pneumonia, pneumoconiosis, radiation pneumonitis, or drug\-induced lung damage 2\) complicated by infectious disease requiring intravenous administration of antifungal agents and/or antibacterial agents 3\) active double cancer 4\) Patients with problematic complication(s) (ex. uncontrol heart disease, serious arrhythmia) 5\) pregnant or lactating women or those who declined contraception 6\) Patients with severe mental illness 7\) Unsuitable patients judged by the attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
Recruiting
Phase 1
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
Completed
Phase 2
Phase II study of nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancerJPRN-UMIN000011681Gifu Municipal Hospital32
Recruiting
Phase 1
Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2on-small-cell lung cancerJPRN-UMIN000014544Shizuoka cancer center33